COMMUNIQUÉ DE PRESSE publié le 18/10/2023 à 14:30, il y a 2 années 11 mois Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
COMMUNIQUÉ DE PRESSE publié le 12/10/2023 à 14:30, il y a 2 années 11 mois Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
COMMUNIQUÉ DE PRESSE publié le 10/10/2023 à 14:30, il y a 2 années 11 mois Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:30, il y a 2 années 11 mois Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
COMMUNIQUÉ DE PRESSE publié le 27/09/2023 à 14:30, il y a 2 années 11 mois Jaguar Health Launches TikTok and Instagram Contest to Raise Awareness About Common Yet Barely Addressed Health Condition: Surprise Diarrhea
COMMUNIQUÉ DE PRESSE publié le 26/09/2023 à 14:30, il y a 2 années 11 mois Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
COMMUNIQUÉ DE PRESSE publié le 21/09/2023 à 13:30, il y a 3 années Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD
COMMUNIQUÉ DE PRESSE publié le 14/09/2023 à 14:30, il y a 3 années Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference
COMMUNIQUÉ DE PRESSE publié le 13/09/2023 à 14:30, il y a 3 années Patent Issued in Japan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
COMMUNIQUÉ DE PRESSE publié le 12/09/2023 à 14:30, il y a 3 années Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
Publié le 24/09/2026 à 18:31, il y a 2 heures 30 minutes LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Publié le 24/09/2026 à 18:00, il y a 3 heures 1 minute GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Publié le 24/09/2026 à 18:00, il y a 3 heures 1 minute GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
Publié le 24/09/2026 à 14:55, il y a 6 heures 6 minutes Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Publié le 24/09/2026 à 14:30, il y a 6 heures 31 minutes Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Publié le 24/09/2026 à 14:00, il y a 7 heures 1 minute Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026
Publié le 24/09/2026 à 14:00, il y a 7 heures 1 minute Reeflex Completes $1.23 Million Goes Order on Schedule Ahead of Vancouver Investor Conference
Publié le 24/09/2026 à 20:29, il y a 32 minutes EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Publié le 24/09/2026 à 19:00, il y a 2 heures 1 minute HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Publié le 24/09/2026 à 18:40, il y a 2 heures 21 minutes EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Publié le 24/09/2026 à 18:15, il y a 2 heures 46 minutes Epanko Value Engineering Identifies 20% Production Increase
Publié le 24/09/2026 à 18:05, il y a 2 heures 56 minutes DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026
